Ally Financial Valuation
Is ALLY1 * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ALLY1 * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ALLY1 * (MX$664.5) is trading above our estimate of fair value (MX$210.54)
Significantly Below Fair Value: ALLY1 * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ALLY1 *?
Other financial metrics that can be useful for relative valuation.
What is ALLY1 *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$11.97b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | n/a |
PEG Ratio | 0.6x |
Price to Earnings Ratio vs Peers
How does ALLY1 *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 7.4x | ||
GENTERA * Gentera. de | 8.7x | 16.3% | Mex$42.3b |
FINDEP * Financiera Independencia. de SOFOM E.N.R | 4.4x | n/a | Mex$3.2b |
GPROFUT * Grupo Profuturo. de | 10.1x | n/a | Mex$28.9b |
SYF Synchrony Financial | 6.3x | -9.2% | US$18.3b |
ALLY1 * Ally Financial | 16x | 25.3% | Mex$12.0b |
Price-To-Earnings vs Peers: ALLY1 * is expensive based on its Price-To-Earnings Ratio (16x) compared to the peer average (7.4x).
Price to Earnings Ratio vs Industry
How does ALLY1 *'s PE Ratio compare vs other companies in the Global Consumer Finance Industry?
Price-To-Earnings vs Industry: ALLY1 * is expensive based on its Price-To-Earnings Ratio (16x) compared to the Global Consumer Finance industry average (13x).
Price to Earnings Ratio vs Fair Ratio
What is ALLY1 *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 16x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate ALLY1 *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$730.58 0% | 13.2% | Mex$916.41 | Mex$560.03 | n/a | 18 |
Apr ’25 | n/a | Mex$682.72 0% | 16.0% | Mex$877.90 | Mex$463.79 | n/a | 18 |
Mar ’25 | Mex$603.00 | Mex$685.55 +13.7% | 14.5% | Mex$872.01 | Mex$478.75 | n/a | 20 |
Feb ’25 | Mex$640.60 | Mex$680.12 +6.2% | 14.0% | Mex$871.41 | Mex$478.42 | n/a | 21 |
Jan ’25 | Mex$590.00 | Mex$556.69 -5.6% | 15.7% | Mex$693.40 | Mex$428.22 | n/a | 20 |
Dec ’24 | n/a | Mex$536.75 0% | 18.4% | Mex$694.54 | Mex$382.00 | n/a | 20 |
Nov ’24 | Mex$419.00 | Mex$548.01 +30.8% | 18.6% | Mex$721.19 | Mex$369.61 | n/a | 19 |
Oct ’24 | n/a | Mex$569.41 0% | 17.0% | Mex$784.40 | Mex$383.48 | n/a | 18 |
Sep ’24 | n/a | Mex$556.06 0% | 17.1% | Mex$767.31 | Mex$375.13 | n/a | 18 |
Aug ’24 | n/a | Mex$552.80 0% | 16.2% | Mex$759.87 | Mex$405.27 | n/a | 19 |
Jul ’24 | Mex$454.25 | Mex$542.42 +19.4% | 20.7% | Mex$804.62 | Mex$376.63 | n/a | 19 |
Jun ’24 | n/a | Mex$577.24 0% | 19.9% | Mex$844.88 | Mex$395.48 | n/a | 18 |
May ’24 | Mex$461.10 | Mex$577.24 +25.2% | 19.9% | Mex$844.88 | Mex$395.48 | Mex$664.50 | 18 |
Apr ’24 | Mex$465.00 | Mex$613.76 +32.0% | 22.2% | Mex$919.14 | Mex$396.49 | n/a | 18 |
Mar ’24 | n/a | Mex$646.54 0% | 20.4% | Mex$933.22 | Mex$439.16 | Mex$603.00 | 18 |
Feb ’24 | Mex$605.00 | Mex$653.66 +8.0% | 20.8% | Mex$958.56 | Mex$413.49 | Mex$640.60 | 18 |
Jan ’24 | Mex$477.00 | Mex$640.03 +34.2% | 22.0% | Mex$908.80 | Mex$375.38 | Mex$590.00 | 18 |
Dec ’23 | Mex$500.00 | Mex$621.62 +24.3% | 21.7% | Mex$881.16 | Mex$363.96 | n/a | 18 |
Nov ’23 | Mex$551.50 | Mex$654.17 +18.6% | 19.1% | Mex$907.12 | Mex$453.56 | Mex$419.00 | 18 |
Oct ’23 | Mex$600.00 | Mex$909.35 +51.6% | 23.9% | Mex$1,468.70 | Mex$632.36 | n/a | 19 |
Sep ’23 | Mex$655.00 | Mex$925.59 +41.3% | 22.0% | Mex$1,450.41 | Mex$684.92 | n/a | 19 |
Aug ’23 | n/a | Mex$952.56 0% | 21.8% | Mex$1,473.35 | Mex$695.75 | n/a | 20 |
Jul ’23 | n/a | Mex$1,148.13 0% | 17.5% | Mex$1,548.27 | Mex$764.08 | Mex$454.25 | 20 |
Jun ’23 | Mex$976.87 | Mex$1,159.43 +18.7% | 15.3% | Mex$1,527.39 | Mex$892.63 | n/a | 20 |
May ’23 | n/a | Mex$1,162.14 0% | 14.9% | Mex$1,527.04 | Mex$912.26 | Mex$461.10 | 20 |
Analyst Forecast: Target price is less than 20% higher than the current share price.